HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Julien Grenier Selected Research
Julien Grenier Research Topics
Disease
8
Breast Neoplasms (Breast Cancer)
05/2024 - 11/2019
4
Neoplasms (Cancer)
02/2023 - 07/2014
4
Demyelinating Diseases (Demyelinating Disease)
07/2017 - 06/2011
3
Disease Progression
11/2022 - 07/2014
2
Neutropenia
11/2022 - 07/2014
2
Fatigue
11/2022 - 10/2020
2
Peripheral Nervous System Diseases (PNS Diseases)
01/2020 - 07/2014
2
Neurodegenerative Diseases (Neurodegenerative Disease)
07/2013 - 06/2011
2
Adenocarcinoma
01/2011 - 01/2007
1
Brain Neoplasms (Brain Tumor)
05/2024
1
Triple Negative Breast Neoplasms
01/2023
1
Lymphopenia (Lymphocytopenia)
11/2022
1
Pain (Aches)
07/2021
1
Neoplasm Metastasis (Metastasis)
05/2021
1
Type 2 Diabetes Mellitus (MODY)
01/2020
1
Inflammatory Breast Neoplasms
01/2020
1
Occupational Stress
01/2018
1
Parkinson Disease (Parkinson's Disease)
07/2017
1
Pathologic Processes
01/2017
1
Inflammation (Inflammations)
01/2017
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2014
1
Pneumonia (Pneumonitis)
07/2014
1
Hypoxia (Hypoxemia)
05/2007
1
Adenocarcinoma of Lung
03/2005
1
Lung Neoplasms (Lung Cancer)
03/2005
Drug/Important Bio-Agent (IBA)
4
Hormones (Hormone)
IBA
05/2024 - 11/2019
3
Paclitaxel (Taxol)
FDA Link
Generic
01/2023 - 01/2020
3
Aromatase Inhibitors
IBA
11/2022 - 11/2019
3
Cholesterol
IBA
01/2017 - 06/2011
2
ErbB Receptors (EGF Receptor)
IBA
11/2022 - 03/2005
2
Everolimus
FDA Link
11/2022 - 11/2019
2
Fulvestrant (Faslodex)
FDA Link
11/2022 - 11/2019
2
palbociclib
IBA
11/2022 - 05/2021
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
07/2014 - 01/2011
1
trastuzumab deruxtecan
IBA
05/2024
1
Trastuzumab (Herceptin)
FDA Link
10/2023
1
Maytansine (Maitansine)
IBA
10/2023
1
taxane
IBA
10/2023
1
pertuzumab
IBA
10/2023
1
atezolizumab
IBA
01/2023
1
TOR Serine-Threonine Kinases
IBA
11/2022
1
Anastrozole (Arimidex)
FDA Link
Generic
11/2022
1
Letrozole (Femara)
FDA Link
Generic
11/2022
1
exemestane (Aromasin)
FDA Link
11/2022
1
DNA (Deoxyribonucleic Acid)
IBA
11/2022
1
eribulin
FDA Link
12/2020
1
Bevacizumab (Avastin)
FDA Link
12/2020
1
3-acetylpyridine adenine dinucleotide (APAD)
IBA
10/2020
1
NAD (NADH)
IBA
01/2020
1
pembrolizumab
IBA
01/2020
1
Monoclonal Antibodies
IBA
01/2020
1
Mechanistic Target of Rapamycin Complex 1
IBA
11/2019
1
Estrogen Receptors
IBA
11/2019
1
Mechanistic Target of Rapamycin Complex 2
IBA
11/2019
1
vistusertib
IBA
11/2019
1
Antidepressive Agents (Antidepressants)
IBA
01/2018
1
Paraquat
IBA
07/2017
1
Myelin Proteins
IBA
07/2017
1
Herbicides
IBA
07/2017
1
Free Radicals
IBA
07/2017
1
Lysophosphatidylcholines (Lysophosphatidylcholine)
IBA
06/2015
1
Gemcitabine
FDA Link
07/2014
1
Transaminases (Aminotransferases)
IBA
07/2014
1
Cetuximab (Erbitux)
FDA Link
07/2014
1
Platinum
IBA
07/2014
1
Cisplatin (Platino)
FDA Link
Generic
07/2014
1
Lithium
IBA
03/2012
1
Oxysterols
IBA
06/2011
1
folfirinox
IBA
01/2011
1
Fluorouracil (Carac)
FDA Link
Generic
01/2011
1
Leucovorin (Folinic Acid)
FDA Link
01/2011
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2011
1
Oxygen (Dioxygen)
IBA
05/2007
1
Biomarkers (Surrogate Marker)
IBA
01/2007
Therapy/Procedure
8
Therapeutics
02/2023 - 01/2011
4
Drug Therapy (Chemotherapy)
10/2023 - 01/2011
2
Radiotherapy
05/2021 - 10/2020
1
Massage (Zone Therapy)
07/2021
1
Adjuvant Chemotherapy
10/2020